These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 10911013

  • 1. Metabolic staging of lung cancer.
    Berlangieri SU, Scott AM.
    N Engl J Med; 2000 Jul 27; 343(4):290-2. PubMed ID: 10911013
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Summaries for patients. Detecting spread of non-small-cell lung cancer within the chest.
    Ann Intern Med; 2003 Dec 02; 139(11):I18. PubMed ID: 14644905
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Staging non-small cell lung cancer.
    Armstrong P, Vincent JM.
    Clin Radiol; 1993 Jul 02; 48(1):1-10. PubMed ID: 8396520
    [No Abstract] [Full Text] [Related]

  • 10. FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls.
    Vansteenkiste JF.
    Lung Cancer; 2005 Feb 02; 47(2):151-3. PubMed ID: 15639713
    [No Abstract] [Full Text] [Related]

  • 11. How useful is positron emission tomography for lymphnode staging in non-small-cell lung cancer?
    Liewald F, Grosse S, Storck M, Guhlmann A, Halter G, Reske S, Sunder-Plassmann L.
    Thorac Cardiovasc Surg; 2000 Apr 02; 48(2):93-6. PubMed ID: 11028710
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Positron-emission tomography (PET) superior to computed tomography for staging and detecting metastasis.
    Timms B.
    Eur J Cancer; 2000 Oct 02; 36(15):1888. PubMed ID: 11186437
    [No Abstract] [Full Text] [Related]

  • 15. Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response.
    Truong MT, Viswanathan C, Erasmus JJ.
    J Thorac Imaging; 2011 May 02; 26(2):132-46. PubMed ID: 21508735
    [Abstract] [Full Text] [Related]

  • 16. The power of synergy in the mediastinal staging of lung cancer.
    Lucignani G.
    Eur J Nucl Med Mol Imaging; 2008 Jul 02; 35(7):1388-91. PubMed ID: 18465126
    [No Abstract] [Full Text] [Related]

  • 17. Mediastinal staging in non-small-cell lung cancer.
    Malenka DJ, Colice GL, Jacobs C, Beck JR.
    Med Decis Making; 1989 Jul 02; 9(4):231-42. PubMed ID: 2552250
    [Abstract] [Full Text] [Related]

  • 18. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.
    Ung YC, Maziak DE, Vanderveen JA, Smith CA, Gulenchyn K, Lacchetti C, Evans WK, Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care.
    J Natl Cancer Inst; 2007 Dec 05; 99(23):1753-67. PubMed ID: 18042932
    [Abstract] [Full Text] [Related]

  • 19. Detection of scalene lymph node metastases from lung cancer. Positron emission tomography.
    Scott WJ, Gobar LS, Hauser LG, Sunderland JJ, Dewan NA, Sugimoto JT.
    Chest; 1995 Apr 05; 107(4):1174-6. PubMed ID: 7705136
    [Abstract] [Full Text] [Related]

  • 20. New horizons in staging for non-small-cell lung cancer.
    Lardinois D.
    J Clin Oncol; 2006 Apr 20; 24(12):1785-7. PubMed ID: 16567767
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.